750
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Individual FEV1 Trajectories Can Be Identified from a COPD Cohort

, , , , &
Pages 425-430 | Received 02 Nov 2014, Accepted 13 Mar 2015, Published online: 25 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hannah R Whittaker, Jeanne M Pimenta, Deborah Jarvis, Steven J Kiddle & Jennifer K Quint. (2020) Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3079-3091.
Read now
Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Esther Rodriguez, Alexa Nuñez, Francisco Casas-Maldonado, Ignacio Blanco, Pietro Pirina, Beatriz Lara & Marc Miravitlles. (2018) Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT). International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1001-1007.
Read now
José Luis López-Campos, Alberto Fernández-Villar, Cristina Represas Represas, Lucía Marín Barrera, Maribel Botana Rial, Cecilia López Ramírez & Ricard Casamor. (2017) Evaluation of clinical variables according to follow-up times in COPD: results from ON-SINT cohort. European Clinical Respiratory Journal 4:1.
Read now

Articles from other publishers (7)

Helena Backman, Anders Blomberg, Anders Lundquist, Viktor Strandkvist, Sami Sawalha, Ulf Nilsson, Jonas Eriksson-Ström, Linnea Hedman, Caroline Stridsman, Eva Rönmark & Anne Lindberg. (2023) Lung Function Trajectories and Associated Mortality Among Adults with and without Airway Obstruction. American Journal of Respiratory and Critical Care Medicine.
Crossref
Vasilis Nikolaou, Sebastiano Massaro, Wolfgang Garn, Masoud Fakhimi, Lampros Stergioulas & David Price. (2021) The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbidities. Respiratory Medicine 186, pages 106528.
Crossref
Anees ur Rehman, Shahid Shah, Ghulam Abbas, Sabariah Noor Harun, Sadia Shakeel, Rabia Hussain, Mohamed Azmi Ahmad Hassali & Muhammad Fawad Rasool. (2021) Assessment of risk factors responsible for rapid deterioration of lung function over a period of one year in patients with chronic obstructive pulmonary disease. Scientific Reports 11:1.
Crossref
Jonas Eriksson Ström, Jamshid Pourazar, Robert Linder, Anders Blomberg, Anne Lindberg, Anders Bucht & Annelie F. Behndig. (2020) Airway regulatory T cells are decreased in COPD with a rapid decline in lung function. Respiratory Research 21:1.
Crossref
Jonas Eriksson Ström, Jamshid Pourazar, Robert Linder, Anders Blomberg, Anne Lindberg, Anders Bucht & Annelie F. Behndig. (2018) Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking. RESPIRATORY RESEARCH 19:1.
Crossref
Serhat Erol, Elif Sen, Yagmur Gizem Kilic, Ahmed Yousif, Oznur Akkoca Yildiz, Turan Acican & Sevgi Saryal. (2018) Does the 2017 revision improve the ability of GOLD to predict risk of future moderate and severe exacerbation?. The Clinical Respiratory Journal 12:8, pages 2354-2360.
Crossref
Philip J. Lawrence, Umme Kolsum, Vandana Gupta, Gavin Donaldson, Richa Singh, Bethan Barker, Leena George, Adam Webb, Anthony J. Brookes, Christopher Brightling, Jadwiga Wedzicha & Dave Singh. (2017) Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients. BMC Pulmonary Medicine 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.